Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Beverly Winikoff, MD, MPH
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service
The study seeks to test whether it is feasible and acceptable for both women and providers (in this context the Lady Health Visitor) to use the semi-quantitative pregnancy test (SQPT) as a...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifep...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)
A double-blind randomized controlled trial to compare a shorter interval between the administration of mifepristone and misoprostol (simultaneous administration compared to 24hours from ad...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation
This double-blind, randomized study will compare the efficacy and acceptability of mifepristone 200mg followed in 36-48 hours by 400mcg or 800mcg of buccal misoprostol (i.e., in the cheeks...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
De-Medicalizing Mifepristone Medical Abortion
This study will investigate the possibility that medical abortion using mifepristone and misoprostol - a safe, proven therapy for terminating early first trimester pregnancy - can be admin...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India
This study compares two community-level strategies: selective administration of 800 mcg sublingual misoprostol to women at 350 mL blood loss for secondary prevention of postpartum hemorrha...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 5 ans
Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)
This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of buccal misoprostol (i.e., in the cheek) taken 24 hours following administration of mifepristo...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion
The primary goal of this study is to directly compare repeat doses of sublingual and buccal routes of 400 mcg misoprostol following mifepristone for second trimester abortion in order to d...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
The purpose of the proposed study is to test - in a randomized, blinded trial - two different doses of the prostaglandin E1 analogue misoprostol administered buccally as a treatment for fe...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Beverly Winikoff, MD, MPH
Update Il y a 4 ans
Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of sublingual misoprostol (i.e., under the tongue) taken 24 hours following administration of mi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
Next